original ) (raw )A Clinical PET Imaging Tracer ([18F]DASA-23) to Monitor Pyruvate Kinase M2–Induced Glycolytic Reprogramming in Glioblastoma
Samantha Reyes
Clinical Cancer Research, 2021
View PDFchevron_right
PET imaging of tumor glycolysis downstream of hexokinase through noninvasive measurement of pyruvate kinase M2
Deepika Bodapati , Edwin Chang
Science translational medicine, 2015
View PDFchevron_right
Preoperative imaging of glioblastoma patients using hyperpolarized 13C pyruvate: Potential role in clinical decision making
Bruce Mickey
Neuro-Oncology Advances, 2021
View PDFchevron_right
Detecting response of rat C6 glioma tumors to radiotherapy using hyperpolarized [1-13C]pyruvate and 13C magnetic resonance spectroscopic imaging
James Mitchell , Martin Lizak
Magnetic Resonance in Medicine, 2011
View PDFchevron_right
Role of PET in the management of gliomas: The radiopharmacist's and clinician's point of view
P. Payoux
Médecine Nucléaire, 2015
View PDFchevron_right
Amino Acid PET Imaging of the Early Metabolic Response During Tumor-Treating Fields (TTFields) Therapy in Recurrent Glioblastoma
Csaba Juhász
Clinical Nuclear Medicine, 2018
View PDFchevron_right
Imaging biological activity of a glioblastoma treated with an individual patient-tailored, experimental therapy regimen
Michael Schroeter
Journal of Neuro-Oncology, 2009
View PDFchevron_right
Refining the Role of Pyruvate Dehydrogenase Kinases in Glioblastoma Development
Gro Rosland
Cancers
View PDFchevron_right
The Assessment of Glioblastoma Metabolic Activity via 11C-Methionine PET and Radiomics
Michael Shifrin
Studies in health technology and informatics, 2023
View PDFchevron_right
A prospective PET study of patients with glioblastoma multiforme
Ulrik Lassen
Acta Neurologica Scandinavica, 2006
View PDFchevron_right
Magnetic Resonance Imaging Is More Sensitive Than PET for Detecting Treatment-Induced Cell Death–Dependent Changes in Glycolysis
Maria Fala
Cancer Research, 2019
View PDFchevron_right
Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constant
Thomas Lewellen
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1998
View PDFchevron_right
The pre-requisite of a second-generation glioma PET biomarker
K. Borbély , László Bognár
View PDFchevron_right
Feasibility of imaging pentose cycle glucose metabolism in gliomas with PET: studies in rat brain tumor models
Mark Muzi
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1997
View PDFchevron_right
Metabolic Assessment of Gliomas Using 11C-Methionine, [18F] Fluorodeoxyglucose, and 11C-Choline Positron-Emission Tomography
Akihisa Okumura
American Journal of Neuroradiology, 2008
View PDFchevron_right
Detection of metabolic change in glioblastoma cells after radiotherapy using hyperpolarized 13 C‐MRI
Tatsuya Kawai
NMR in Biomedicine, 2021
View PDFchevron_right
18F-fluorothymidine-pet imaging of glioblastoma multiforme: effects of radiation therapy on radiotracer uptake and molecular biomarker patterns
Gary Kao
TheScientificWorldJournal, 2013
View PDFchevron_right
PET Imaging in Glioma
Krisztian Homicsko
PET Clinics, 2013
View PDFchevron_right
EPR oxygen imaging and hyperpolarized 13 C MRI of pyruvate metabolism as noninvasive biomarkers of tumor treatment response to a glycolysis inhibitor 3-bromopyruvate
Martin Lizak
Magnetic Resonance in Medicine, 2013
View PDFchevron_right
Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas
K. Borbély
Journal of the Neurological Sciences, 2006
View PDFchevron_right
Molecular imaging of regional brain tumor biology
Mark Muzi
Journal of Cellular Biochemistry, 2002
View PDFchevron_right
Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging
Robert Downey
Clinical Positron Imaging, 1999
View PDFchevron_right
Two-grade metabolic tumour tissue assessment using positron emission tomography in prediction of overall survival in glioblastoma patients
Milos Lucic
Vojnosanitetski pregled, 2020
View PDFchevron_right
Effective Detection and Monitoring of Glioma Using [18F]FPIA PET Imaging
Chris Barnes
Biomedicines
View PDFchevron_right
Pyruvate Kinase M2: a Metabolic Bug in Re-Wiring the Tumor Microenvironment
Amit Khairnar
Cancer Microenvironment, 2019
View PDFchevron_right
Prognostic Value of O-(2-18F-Fluoroethyl)-L-Tyrosine PET and MRI in Low-Grade Glioma
Hans-jakob Steiger
Journal of Nuclear Medicine, 2007
View PDFchevron_right
The Path Toward PET-Guided Radiation Therapy for Glioblastoma in Laboratory Animals: A Mini Review
Julie Bolcaen
Frontiers in Medicine
View PDFchevron_right